These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 37139652)

  • 41. Anti-HIV agents. The changing picture of HIV.
    TreatmentUpdate; 2009 Feb; 21(2):1-3. PubMed ID: 19391260
    [No Abstract]   [Full Text] [Related]  

  • 42. Editorial comment: treating the experienced patient--when and how to use new agents.
    Gallant JE
    AIDS Read; 2006 May; 16(5):274-5. PubMed ID: 16764069
    [No Abstract]   [Full Text] [Related]  

  • 43. Facing new challenges to promote long-term health for people living with HIV.
    Dockrell DH
    Curr Opin Infect Dis; 2017 Feb; 30(1):1-3. PubMed ID: 27845953
    [No Abstract]   [Full Text] [Related]  

  • 44. Positive attitude towards antiretroviral therapy after 6 months of treatment in a sample of Dutch HIV infected people.
    Reedijk M; Bindels PJ; Wigersma L
    Sex Transm Infect; 1999 Jun; 75(3):204. PubMed ID: 10448410
    [No Abstract]   [Full Text] [Related]  

  • 45. Antiretroviral agents used in the treatment of HIV infections.
    Harris W; Brown G
    ABNF J; 2001; 12(3):67-9. PubMed ID: 11760502
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Factors that do not inform HIV providers' decisions to start antiretroviral therapy for young people living with behaviorally acquired HIV.
    Ball JD
    J Adolesc Health; 2015 Jan; 56(1):120. PubMed ID: 25530604
    [No Abstract]   [Full Text] [Related]  

  • 47. Toward an endgame: finding and engaging people unaware of their HIV-1 infection in treatment and prevention.
    Burns DN; DeGruttola V; Pilcher CD; Kretzschmar M; Gordon CM; Flanagan EH; Duncombe C; Cohen MS
    AIDS Res Hum Retroviruses; 2014 Mar; 30(3):217-24. PubMed ID: 24410300
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HIV treatment guidelines revised.
    AIDS Patient Care STDS; 2010 Jan; 24(1):65. PubMed ID: 20136416
    [No Abstract]   [Full Text] [Related]  

  • 49. Clinical management of treatment-experienced, HIV/AIDS patients in the combination antiretroviral therapy era.
    Boyd MA; Hill AM
    Pharmacoeconomics; 2010; 28 Suppl 1():17-34. PubMed ID: 21182341
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ibalizumab for the treatment of multidrug-resistant HIV-1 infection.
    Rizza SA; Bhatia R; Zeuli J; Temesgen Z
    Drugs Today (Barc); 2019 Jan; 55(1):25-34. PubMed ID: 30740610
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Successful use of the potent enzyme inducer enzalutamide in a treatment-experienced HIV-positive male with prostate cancer.
    Nhean S; Bravo J; Sheehan NL; Walmsley S; Tilley D; Tseng AL
    AIDS; 2018 Nov; 32(17):2640-2642. PubMed ID: 30379691
    [No Abstract]   [Full Text] [Related]  

  • 52. Maraviroc--new HIV drug. Emerging options need to be used wisely.
    Vázquez E
    Posit Aware; 2007; 18(4):18-9. PubMed ID: 17682275
    [No Abstract]   [Full Text] [Related]  

  • 53. Seeking ethical designs for HIV clinical trials in treatment-experienced patients: an industry perspective.
    Mayers DL; Chung J; Kohlbrenner VM; Hall DB; DeMasi RA; Neubacher D; Buss NE; Salgo MP
    AIDS Res Hum Retroviruses; 2006 Nov; 22(11):1110-2. PubMed ID: 17147497
    [No Abstract]   [Full Text] [Related]  

  • 54. New drug treatment options for HIV antiretroviral therapy.
    Kwong J
    Nurse Pract; 2020 Mar; 45(3):28-38. PubMed ID: 31996579
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Meeting notes from ICAAC. D-D4FC (Reverset): further data on treatment-experienced patients.
    Sax PE
    AIDS Clin Care; 2005 Jan; 17(1):8. PubMed ID: 15717377
    [No Abstract]   [Full Text] [Related]  

  • 56. [Antiretroviral treatment].
    Nielsen HI
    Ugeskr Laeger; 1999 Mar; 161(12):1731. PubMed ID: 10210968
    [No Abstract]   [Full Text] [Related]  

  • 57. Drug therapy in ARV-experienced patients. Interview by Vicki Glaser.
    Tapper ML
    AIDS Patient Care STDS; 2003 Oct; 17(10):491-4. PubMed ID: 14588088
    [No Abstract]   [Full Text] [Related]  

  • 58. Anti-HIV agents. Treatments for drug-resistant HIV coming.
    TreatmentUpdate; 2007; 19(5):1-2. PubMed ID: 17955612
    [No Abstract]   [Full Text] [Related]  

  • 59. Medical-legal issues in HIV treatment: Part 1.
    Bradley T; Bradley H; Boyle BA
    AIDS Read; 2001 Apr; 11(4):182-3, 188-90. PubMed ID: 11392676
    [No Abstract]   [Full Text] [Related]  

  • 60. Structured treatment interruptions to control HIV-1 infection.
    Lori F; Maserati R; Foli A; Seminari E; Timpone J; Lisziewicz J
    Lancet; 2000 Jan; 355(9200):287-8. PubMed ID: 10675080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.